Skip to main content

Peer Review reports

From: Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects

Original Submission
30 Jun 2022 Submitted Original manuscript
12 Jul 2022 Author responded Author comments - Feifei Sun
Resubmission - Version 2
12 Jul 2022 Submitted Manuscript version 2
19 Jul 2022 Author responded Author comments - Feifei Sun
Resubmission - Version 3
19 Jul 2022 Submitted Manuscript version 3
2 Aug 2022 Reviewed Reviewer Report - Aydın Erenmemişoğlu
28 Aug 2022 Reviewed Reviewer Report
11 Nov 2022 Author responded Author comments - Feifei Sun
Resubmission - Version 4
11 Nov 2022 Submitted Manuscript version 4
2 Dec 2022 Reviewed Reviewer Report - Aydın Erenmemişoğlu
7 Dec 2022 Reviewed Reviewer Report
17 Dec 2022 Author responded Author comments - Feifei Sun
Resubmission - Version 5
17 Dec 2022 Submitted Manuscript version 5
16 Jan 2023 Author responded Author comments - Feifei Sun
Resubmission - Version 6
16 Jan 2023 Submitted Manuscript version 6
Publishing
25 Jan 2023 Editorially accepted
3 Feb 2023 Article published 10.1186/s40360-023-00649-y

You can find further information about peer review here.

Back to article page